Characteristics of GII.4 Norovirus Versus Other Genotypes in Sporadic Pediatric Infections in Davidson County, Tennessee, USA
Authors:
Open Access
- 15 July 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 73 (7) , e1525-e1531
Abstract
Background: Norovirus is a leading cause of epidemic acute gastroenteritis (AGE), with most outbreaks occurring during winter. The majority of outbreaks are caused by GII.4 noroviruses; however, data to support whether this is true for sporadic medically attended AGE are limited. Therefore, we sought to compare the clinical characteristics and seasonality of GII.4 vs non-GII.4 viruses. Methods: Children aged 15 days -17 years with AGE symptoms were recruited from the outpatient, emergency department, and inpatient settings at Vanderbilt Children’s Hospital, Davidson County, Nashville, Tennessee, from December 2012 -November 2015. Stool specimens were tested using qRT-PCR for GI and GII noroviruses and subsequently genotyped by sequencing a partial region of the capsid gene. Results: A total of 3705 patients were enrolled, and stool specimens were collected and tested from 2885 (78%) enrollees. Overall, 636 (22%) samples were norovirus-positive, of which 567 (89%) were GII. Of the 460 (81%) genotyped GII-positive samples, 233 (51%) were typed as GII.4 and 227 (49%) as non-GII.4. Compared with children with non-GII.4 infections, children with GII.4 infections were younger, more likely to have diarrhea, and more likely to receive oral rehydration fluids. Norovirus was detected year-round and peaked during winter. Conclusions: Approximately 40% of sporadic pediatric norovirus AGE cases were caused by GII.4 norovirus. Children infected with GII.4 had more severe symptoms that required more medical care. Seasonal variations were noticed among different genotypes. These data highlight the importance of continuous norovirus surveillance and provide important information on which strains pediatric norovirus vaccines should protect against.Keywords
Funding Information
- Centers for Disease Control and Prevention (CDC) Cooperative (U01IP001063, UL1 TR000445)
- National Center for Advancing Translational Sciences
- National Institutes of Health
This publication has 40 references indexed in Scilit:
- Effects and Clinical Significance of GII.4 Sydney Norovirus, United States, 2012–2013Emerging Infectious Diseases, 2013
- Epidemiology of Foodborne Norovirus Outbreaks, United States, 2001–2008Emerging Infectious Diseases, 2012
- Severe Outcomes Are Associated With Genogroup 2 Genotype 4 Norovirus Outbreaks: A Systematic Literature ReviewClinical Infectious Diseases, 2012
- Novel Surveillance Network for Norovirus Gastroenteritis Outbreaks, United StatesEmerging Infectious Diseases, 2011
- Norovirus GII-4 Causes a More Severe Gastroenteritis Than Other Noroviruses in Young ChildrenThe Journal of Infectious Diseases, 2011
- Molecular Epidemiology of Genogroup II-Genotype 4 Noroviruses in the United States between 1994 and 2006Journal of Clinical Microbiology, 2010
- Differences in clinical presentation between norovirus genotypes in nursing homesJournal of Clinical Virology, 2009
- Active, Population-Based Surveillance for Severe Rotavirus Gastroenteritis in Children in the United StatesPediatrics, 2008
- Norovirus pathogenesis: mechanisms of persistence and immune evasion in human populationsImmunological Reviews, 2008
- Mechanisms of GII.4 Norovirus Persistence in Human PopulationsPLOS Medicine, 2008